戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 xtending the intervention period may improve treatment effectiveness.
2 viral load testing is recommended to monitor treatment effectiveness.
3  differentiation factor 15 antibody enhanced treatment effectiveness.
4 g challenges in evaluating exposure or water treatment effectiveness.
5  However, their low specificity limits their treatment effectiveness.
6 ent-reported measure of disease severity and treatment effectiveness.
7  (18)F-FdCyd imaging as a predictor of FdCyd treatment effectiveness.
8 n merging with cellular membranes to enhance treatment effectiveness.
9 ors of disease progression and predictors of treatment effectiveness.
10 represent a clinical challenge, mostly about treatment effectiveness.
11 pular and practical approach to questions of treatment effectiveness.
12 the current setting, despite improvements in treatment effectiveness.
13 ogics and their survival in association with treatment effectiveness.
14 t modifiers for survival in association with treatment effectiveness.
15  exams, while DES assessment tests evaluated treatment effectiveness.
16 ting MDR-TB, poses significant threats to TB treatment effectiveness.
17 e receiving treatment raises concerns around treatment effectiveness.
18 s do not remains poorly understood, limiting treatment effectiveness.
19 iome-targeted interventions to improve HNSCC treatment effectiveness.
20 gs of disease biology, patterns of care, and treatment effectiveness.
21 is key patient-centered aspect of evaluating treatment effectiveness.
22 o not have the necessary evidence to support treatment effectiveness.
23 pic children wearing MFCLs might improve the treatment effectiveness.
24 tes improved diagnosis and the evaluation of treatment effectiveness.
25 entify independent variables associated with treatment effectiveness.
26 e, accurate grading is critical for tracking treatment effectiveness.
27 should be treated first in order to increase treatment effectiveness.
28  MRD diagnostics becomes essential to assess treatment effectiveness.
29  baseline IOP was the strongest predictor of treatment effectiveness.
30 neous IFNbeta injection did not enhance GAS6 treatment effectiveness.
31 s the absence of consensus on measurement of treatment effectiveness.
32 e may offer novel targets or measurements of treatment effectiveness.
33 ays after induction chemotherapy to evaluate treatment effectiveness.
34 ability of studies that examine chemotherapy treatment effectiveness.
35 es not remove all biases from evaluations of treatment effectiveness.
36 trogen blockade might thus be a predictor of treatment effectiveness.
37 xed results of previous research and improve treatment effectiveness.
38  is shown to significantly alter the overall treatment effectiveness.
39 responding to radiation and therefore reduce treatment effectiveness.
40 t oxygen, causing acute hypoxia and limiting treatment effectiveness.
41 ng processes, thereby improving accuracy and treatment effectiveness.
42 7 consists of 7 items assessing 3 domains of treatment: effectiveness (3 items), convenience (3 items
43                    Results were sensitive to treatment effectiveness, absolute excess risk for CHF, a
44 n by >=10% and >=20%, relief of symptoms and treatment effectiveness; adverse events; and additional
45 l (Affordability and Real-World Antiplatelet Treatment Effectiveness After Myocardial Infarction Stud
46      Efforts are needed to optimize curative treatment effectiveness among patients with early-stage
47                                              Treatment effectiveness analyses that were stratified by
48  14% (4-28) if the new regimen affected only treatment effectiveness and by 11% (3-24) if it affected
49 ial modifying effects of tobacco exposure on treatment effectiveness and clinical outcomes.
50 e and growth of benign and malignant tumors, treatment effectiveness and costs, and patient outcomes.
51         The model incorporated RCC presence, treatment effectiveness and costs, and short- and long-t
52      Further research is required to examine treatment effectiveness and efficiency.
53 ion) and has implications for assessments of treatment effectiveness and healthcare quality, especial
54 infants, which has the potential to increase treatment effectiveness and improve the quality of life
55 ngle-level intervention (usual care [UC]) on treatment effectiveness and incremental cost-effectivene
56  structure from kidney, endowed MAMA greater treatment effectiveness and lower side effect than chemo
57 are patients led to substantial increases in treatment effectiveness and moderate increases in costs.
58 marker had sufficient information to predict treatment effectiveness and prognosis.
59 ioritize and design interventions to improve treatment effectiveness and reduce spending.
60 HPAI management is a key factor in improving treatment effectiveness and reducing the negative impact
61                          Real-world data for treatment effectiveness and renal outcomes in chronic he
62                                  To optimize treatment effectiveness and resource allocation, a thera
63 ts to specific therapies and then to monitor treatment effectiveness and safety are currently being r
64 ies for psoriasis is a proxy for longer-term treatment effectiveness and safety.
65 al ventilation were found to be modifiers of treatment effectiveness and should be considered when de
66 ice-based research, and the determination of treatment effectiveness and the factors required for suc
67                      We aimed to measure HCV treatment effectiveness and to determine the population
68      We aimed to (1) deliver and measure HCV treatment effectiveness, and (2) determine the populatio
69 pecific medical and surgical treatments, (3) treatment effectiveness, and (4) population trends in ma
70  early detection of drug-resistance, improve treatment effectiveness, and address non-communicable di
71  allowing timely diagnosis, verifications of treatment effectiveness, and developments of new medicin
72 is review is to examine service utilization, treatment effectiveness, and future directions for adole
73 of topics, including epidemiology, genetics, treatment effectiveness, and health policy.
74  to solve biologic questions, improve cancer treatment effectiveness, and inspire clinical translatio
75 age underlying causes, follow up to evaluate treatment effectiveness, and offer opioids in advanced c
76 h standard diagnostic work-up accuracy, drug treatment effectiveness, and version of the Health Utili
77 d ability to identify new lesions to monitor treatment effectiveness, and we provide recommendations
78 f tuberculosis without treatment, and 20-60% treatment effectiveness, approximately 4,000-11,000 tube
79               New methods of assessing early treatment effectiveness are being developed.
80 ale, class 1 randomised controlled trials on treatment effectiveness are scarce.
81 ive the uncertainty regarding a reduction in treatment effectiveness as acceptable while others may n
82 munity residence, seems to have had the same treatment effectiveness as acute hospital care for urban
83             The kinetic parameters (epsilon, treatment effectiveness at inhibiting virion production;
84                                         High treatment effectiveness by non-specialists demonstrates
85                                         High treatment effectiveness by nonspecialists demonstrates t
86 itored periodically over 11 months to assess treatment effectiveness by tracking lesion development a
87 investigate whether subjective perception of treatment effectiveness changes between the conditioning
88 evaluate the existence of trade-offs between treatment effectiveness, cost, and the dynamics of resis
89 ecific microbiome signatures associated with treatment effectiveness could provide novel prognostic b
90        More research is necessary to confirm treatment effectiveness, duration of required treatment,
91 o damage after stroke in sleep and attenuate treatment effectiveness during the active phase.
92 clinical trials provide the best evidence of treatment effectiveness; factors determining their impac
93 ecommended the trial be stopped early due to treatment effectiveness following the 12-month post-base
94 ubstantial impact on our capacity to enhance treatment effectiveness for a broad range of chronic con
95  have been shown to be an early indicator of treatment effectiveness for breast cancer, mainly in the
96 ghts the importance of ongoing evaluation of treatment effectiveness, given the dynamic nature of the
97     The discovery of biomarkers that predict treatment effectiveness has great potential for improvin
98 ome that should be evaluated as a measure of treatment effectiveness in future studies of diabetic ey
99                           Further studies of treatment effectiveness in genotypes 2d and 2b are indic
100                                              Treatment effectiveness in hepatocellular carcinoma (HCC
101 hemoresistance development and could predict treatment effectiveness in HGSOC patients.
102 s should be followed up (re-examination) and treatment effectiveness in patients with specific charac
103 sumptions about pre-treatment water quality; treatment effectiveness in reducing bacteria, viruses, a
104                  3) What is the evidence for treatment effectiveness in reducing depression in HF pat
105 tric methods for causal analysis to estimate treatment effectiveness in these trial-underrepresented
106                        Information regarding treatment effectiveness in this age group and tools that
107 s remain as to the selection of patients for treatment, effectiveness in fracture prevention, which b
108    This cohort/registry study of comparative treatment effectiveness included data from 7 specialist
109 extent to which portrayals of mental illness treatment effectiveness influence personal beliefs and p
110                                    Decreased treatment effectiveness is associated with biofilm forma
111 of medication adherence required for optimal treatment effectiveness is extremely high.
112 ion, but the effect of surface conditions on treatment effectiveness is not well understood.
113 ne of therapy for this debilitating disease, treatment effectiveness is often hampered by the develop
114 used to treat rotator cuff disorders but the treatments' effectiveness is uncertain.
115  to a wide range of assumptions about costs, treatment effectiveness, level of risk for cardiovascula
116 re access requirements, COVID-19 impact, and treatment effectiveness, machine models were used to qua
117 se results suggest that significant gains in treatment effectiveness may be obtained by combining the
118 paratively improve AD flares as a measure of treatment effectiveness may facilitate shared decision-m
119 ded appendectomy within 1 year, resulting in treatment effectiveness of 72.6%, significantly lower th
120 ection with a treatment cost of $100,000 and treatment effectiveness of 90%.
121 e, PRO may help to better understand overall treatment effectiveness of a new drug being tested.
122 re (Brief-IPQ), plays a decisive role in the treatment effectiveness of a wide range of chronic disea
123 ose To evaluate the feasibility, safety, and treatment effectiveness of ablative chemoembolization (A
124                                    Long-term treatment effectiveness of antiretroviral drugs is often
125                                              Treatment effectiveness of Helicobacter pylori varies re
126       This field study demonstrated that the treatment effectiveness of Pb stabilization and risk red
127                                              Treatment effectiveness of REGEN-COV was 56.4% (95% CI:
128 orded the opportunity to distinguish between treatment effectiveness of SC, DH, and VC independent of
129               The authors evaluated the post-treatment effectiveness of the edge-to-edge technique us
130            Data were analyzed to compare the treatment effectiveness of the groups; data also were ag
131 placed and had income loss, by comparing the treatment effectiveness of usual care alone, usual care
132 een in cancers affect disease progression or treatment effectiveness or instead are benign.
133 time a link between changes in perception of treatment effectiveness, personality traits and the magn
134 n numbers of CHD patients, treatment uptake, treatment effectiveness, population risk factor trends,
135 o intravitreal injections and concerns about treatment effectiveness, rather than around pain.
136 he impact of FQ-DST was sensitive to overall treatment effectiveness, regimen robustness to loss of f
137 lth record data sources to accurately assess treatment effectiveness remain unclear.
138 ciplinary care and continuous monitoring for treatment effectiveness, safety, and adherence, welcomin
139 ysician and patient visual analog scale, and treatment effectiveness score.
140  SETTING, AND PARTICIPANTS: This comparative treatment effectiveness study included 6 specialist MS c
141 DESIGN, SETTING, AND PARTICIPANTS: The Light Treatment Effectiveness study was an investigator-initia
142 the two races; however, when controlling for treatment effectiveness, these differences were no longe
143 multidrug antimicrobial resistance can limit treatment effectiveness, threatening patient longevity.
144 al randomized clinical trials (RCTs) compare treatment effectiveness to provide support for evidence-
145 lopment of accurate prospective estimates of treatment effectiveness using actual enrollee characteri
146 We examined the effect of treatment delay on treatment effectiveness using logistic regression models
147 attendance (R(2) 0.71), and patient-reported treatment effectiveness variably (R(2) range 0.08-0.41).
148                 The overall second-line mITT treatment effectiveness was 84% in both groups.
149                Results also suggest that CRF treatment effectiveness was associated with cancer stage
150                                              Treatment effectiveness was based on adult data.
151                                    Estimated treatment effectiveness was defined as one minus the haz
152                                              Treatment effectiveness was evaluated in relation to dem
153                                              Treatment effectiveness was evaluated in vivo using clin
154 benchmarked against the trial results before treatment effectiveness was further evaluated based on (
155 ression was low (<33%) and the mean reported treatment effectiveness was only moderate.
156 igate chemoresistance and better predict the treatment effectiveness, we examined two traits: resista
157                                 Estimates of treatment effectiveness were based on the JUPITER trial
158                    Screening performance and treatment effectiveness were estimated based on publishe
159 ity and technology operation that may impact treatment effectiveness when selecting treatment options
160 ulti-dimensional thermometry to evaluate the treatment effectiveness, which can be also assisted by t
161  in which early use of the new drug enhances treatment effectiveness while hastening the rise of high
162 vement in satisfaction on symptom relief and treatment effectiveness with etripamil versus placebo.
163 ic follow-up and outcome assessment, improve treatment effectiveness, with 1 meta-analysis reporting
164                        Limited data exist on treatment effectiveness, with no published randomized cl

 
Page Top